Loading...
0

Varicose Vein Treatment Market by Procedure (Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation and Stripping), Product (sclerotherapy injection, Ablation devices and others) and End User (Hospitals, Clinics, and Ambulatory centers): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

LI_195184
Pages: 175
Feb 2019 | 1697 Views
 
Author(s) : Raghvendra Kumar
Tables: 91
Charts: 18
 

varicose vein treatment market overview:

The global varicose vein treatment market was valued at $ 376.64 million in 2017, and is projected to reach $ 589.06 million by 2025, growing at a CAGR of 5.7% from 2018 to 2025.

Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessels walls. These veins appeared to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at age of 40 and generally appeared in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women. The varicose vein treatment analysis is done on the basis of the exhaustive primary and secondary regional wise to understand the factors responsible for growth and factors hampering the growth of the market.

Factors such as increase in incidence of varicose vein problem, rise in geriatric population, advanced varicose vein treatment devices, engagement in occupation that increases the prevalence of varicose vein treatment and technological advancements globally, drive the growth of the market. Moreover, increase in level of awareness, and development in the emerging markets create numerous opportunities in the varicose vein treatment market.

Get more information on this report: Request Sample Pages

Varicose Vein Treatment Market Segmentation

The global varicose vein treatment market is segmented based on procedure, product and services, end user, and region. Based on product, the market is segmented into endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Based on product, the market is divided into ablation devices, sclerotherapy injection and other. Ablation devices is further bifurcated into radiofrequency ablation devices, laser ablation devices and others. Based on the end user the market is segmented into hospitals, clinics, and ambulatory centers. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment review

Based on procedure, the global varicose vein treatment market is categorized into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. At present, the sclerotherapy segment is the major revenue generating segment as the sclerotherapy procedure is a painless procedure and on the same day of surgery the patient can go to home.

Get more information on this report: Request Sample Pages

Based on product, the global varicose vein treatment market is categorized into sclerotherapy injection, ablation devices and others. At present, the sclerotherapy injection is the major revenue generating segment as surgery with ablation devices is less painful and leaves no stretch marks. Patients can go home on the same day of the surgery.

Get more information on this report: Request Sample Pages

Based on end user, the global varicose vein treatment market is categorized into hospitals, clinics, and home use. At present, the hospital segment is the major revenue generating segment due to availability of nurse and healthcare professionals who offer proper guidance about handling the device.

Get more information on this report: Request Sample Pages

Snapshot of Asia-Pacific varicose vein treatment market

Asia-Pacific provides lucrative growth opportunities for the key players operating in the varicose vein treatment market due to high population base, development in healthcare infrastructure, and increase in geriatric population. However, as insurance companies do not cover the entire material expenses of a surgery, it is estimated to hamper the market growth in Asia-Pacific.

Get more information on this report: Request Sample Pages

The key players profiled in this report include Medtronic, Lumenis, Alma Lasers Ltd., Angiodynamics, Inc., Biolitec AG, BTG PLC, Energist Ltd., Sciton Inc., WONTECH Co., Ltd., and Syneron.

Key Benefits for varicose vein treatment market:

  • The study provides an in-depth analysis of the varicose vein treatment market size along with the current trends and future estimations to elucidate the imminent investment pockets.

  • It offers a quantitative analysis varicose vein treatment market trends from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

  • A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities in the varicose vein treatment market share.

  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global varicose vein treatment market growth.

varicose vein treatment Key Market Segments:

By Procedure

  • Injection Sclerotherapy

  • Endovenous Ablation

  • Surgical Ligation/Stripping

By Product

  • Sclerotherapy Injection

  • Ablation Devices

    • Radiofrequency Ablation Devices

    • Laser Ablation Devices

    • Others

  • Others

By End User

  • Hospitals

  • Clinics

  • Ambulatory centers

By Region

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • Australia

    • India

    • South Korea

    • Rest of Asia-Pacific

  • LAMEA

    • Brazil

    • Saudi Arabia

    • South Africa

    • Rest of LAMEA

 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key Market Segments

1.3.1.    List of key players profiled in the report:

1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key findings of the study
2.2.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    key findings

3.2.1.    Top investment pockets
3.2.2.    Top player positioning

3.3.    Market dynamics

3.3.1.    Drivers

3.3.1.1.    Increasing geriatric population
3.3.1.2.    Advanced varicose vein treatment devices
3.3.1.3.    Engagement in occupation that increases the prevalence of varicose vein treatment
3.3.1.4.    Technological advancement

3.3.2.    Restraints

3.3.2.1.    Risk factors associated with the treatment devices and less experienced healthcare professionals

3.3.3.    Opportunities

3.3.3.1.    Increase in level of awareness
3.3.3.2.    Untapped markets in emerging markets

3.3.4.    Impact analysis

CHAPTER 4:    VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Endovenous Ablation

4.2.1.    Key trends and opportunities
4.2.2.    Market size and forecast
4.2.3.    Market analysis, by country

4.3.    Injection Sclerotherapy

4.3.1.    Key trends and opportunities
4.3.2.    Market size and forecast
4.3.3.    Market analysis, by country

4.4.    Surgical Ligation/Stripping

4.4.1.    Key trends and opportunities
4.4.2.    Market size and forecast
4.4.3.    Market analysis, by country

CHAPTER 5:    VARICOSE VEIN TREATMENT MARKET, BY PRODUCT

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Ablation Devices

5.2.1.    Market size and forecast
5.2.2.    Market analysis, by country

5.2.2.1.    Radiofrequency Ablation Devices
5.2.2.2.    Laser ablation devices
5.2.2.3.    Others

5.2.3.    Sclerotherapy Injection
5.2.4.    Market size and forecast
5.2.5.    Market analysis, by country
5.2.6.    Others
5.2.7.    Market size and forecast
5.2.8.    Market analysis, by country

CHAPTER 6:    VARICOSE VEIN TREATMENT MARKET, BY END USER

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Hospitals

6.2.1.    Market size and forecast
6.2.2.    Market analysis, by country

6.3.    Ambulatory Centers

6.3.1.    Market size and forecast
6.3.2.    Market analysis, by country

6.4.    Clinics

6.4.1.    Market size and forecast
6.4.2.    Market analysis, by country

CHAPTER 7:    VARICOSE VEIN TREATMENT MARKET, BY REGION

7.1.    Overview

7.1.1.    Market size and forecast

7.2.    North America

7.2.1.    Key trends and opportunities
7.2.2.    North America market size & forecast, by country

7.2.2.1.    U.S. market size & forecast, by procedure
7.2.2.2.    U.S. market size & forecast, by product
7.2.2.3.    U.S. market size & forecast, by end user
7.2.2.4.    Canada market size & forecast, by procedure
7.2.2.5.    Canada market size & forecast, by product
7.2.2.6.    Canada market size & forecast, by end user
7.2.2.7.    Mexico market size & forecast, by procedure
7.2.2.8.    Mexico market size & forecast, by Product
7.2.2.9.    Mexico market size & forecast, by end user

7.2.3.    North America market size & forecast, by procedure
7.2.4.    North America market size & forecast, by product
7.2.5.    North America market size & forecast, by end user

7.3.    Europe

7.3.1.    Key trends and opportunities
7.3.2.    Europe market size & forecast for varicose vein treatment market, by country

7.3.2.1.    Germany market size & forecast, by procedure
7.3.2.2.    Germany market size & forecast, by product
7.3.2.3.    Germany market size & forecast, by end user
7.3.2.4.    France market size & forecast, by Procedure
7.3.2.5.    France market size & forecast, by product
7.3.2.6.    France market size & forecast, by end user
7.3.2.7.    UK market size & forecast, by procedure
7.3.2.8.    UK market size & forecast, by product
7.3.2.9.    UK market size & forecast, by end user
7.3.2.10.    Italy market size & forecast, by procedure
7.3.2.11.    Italy market size & forecast, by product
7.3.2.12.    Italy market size & forecast, by end user
7.3.2.13.    Spain market size & forecast, by procedure
7.3.2.14.    Spain market size & forecast, by product
7.3.2.15.    Spain market size & forecast, by end user
7.3.2.16.    Rest of Europe market size & forecast, by procedure
7.3.2.17.    Rest of Europe market size & forecast, by product
7.3.2.18.    Rest of Europe market size & forecast, by end user

7.3.3.    Europe market size & forecast, by procedure
7.3.4.    Europe market size & forecast, by product
7.3.5.    Europe market size & forecast, by end user

7.4.    Asia-Pacific

7.4.1.    Key trends and opportunities
7.4.2.    Asia-Pacific market size & forecast, by country

7.4.2.1.    Japan market size & forecast, by procedure
7.4.2.2.    Japan market size & forecast, by product
7.4.2.3.    Japan market size & forecast, by end user
7.4.2.4.    China market size & forecast, by procedure
7.4.2.5.    China market size & forecast, by product
7.4.2.6.    China market size & forecast, by end user
7.4.2.7.    India market size & forecast, by procedure
7.4.2.8.    India market size & forecast, by product
7.4.2.9.    India market size & forecast, by end user
7.4.2.10.    Australia market size & forecast, by procedure
7.4.2.11.    Australia market size & forecast, by product
7.4.2.12.    Australia market size & forecast, by end user
7.4.2.13.    South Korea market size & forecast, by procedure
7.4.2.14.    South Korea market size & forecast, by product
7.4.2.15.    South Korea market size & forecast, by end user
7.4.2.16.    Rest of Asia-Pacific market size & forecast, by procedure
7.4.2.17.    Rest of Asia-Pacific market size & forecast, by product
7.4.2.18.    Rest of Asia-Pacific market size & forecast, by end user

7.4.3.    Asia-Pacific market size & forecast, by procedure
7.4.4.    Asia-Pacific market size & forecast, by product
7.4.5.    Asia-Pacific market size & forecast, by end user

7.5.    LAMEA

7.5.1.    Key trends and opportunities
7.5.2.    LAMEA market size & forecast, by country

7.5.2.1.    Brazil market size & forecast, by procedure
7.5.2.2.    Brazil market size & forecast, by product
7.5.2.3.    Brazil market size & forecast, by end user
7.5.2.4.    South Africa market size & forecast, by procedure
7.5.2.5.    South Africa market size & forecast, by product
7.5.2.6.    South Africa market size & forecast, by end user
7.5.2.7.    Saudi Arabia market size & forecast, by procedure
7.5.2.8.    Saudi Arabia market size & forecast, by product
7.5.2.9.    Saudi Arabia market size & forecast, by end user
7.5.2.10.    Rest of LAMEA market size & forecast, by procedure
7.5.2.11.    Rest of LAMEA market size & forecast, by product
7.5.2.12.    Rest of LAMEA market size & forecast, by end user

7.5.3.    LAMEA market size & forecast, by procedure
7.5.4.    LAMEA market size & forecast, by product
7.5.5.    LAMEA market size & forecast, by end user

CHAPTER 8:    COMPANY PROFILES

8.1.    Angiodynamics Inc

8.1.1.    Company overview
8.1.2.    Company snapshot
8.1.3.    Operating business segments
8.1.4.    Product Portfolio
8.1.5.    Business performance

8.2.    Alma Lasers

8.2.1.    Company overview
8.2.2.    Company snapshot
8.2.3.    Operating business segments
8.2.4.    Product portfolio
8.2.5.    Key strategic moves and developments

8.3.    biolitec AG Untere Viaduktgasse

8.3.1.    Company overview
8.3.2.    Company snapshot
8.3.3.    Operating business segments
8.3.4.    Product portfolio

8.4.    BTG International Ltd

8.4.1.    Company overview
8.4.2.    Company snapshot
8.4.3.    Operating business segments
8.4.4.    Product Portfolio
8.4.5.    Business performance

8.5.    Energist Ltd

8.5.1.    Company overview
8.5.2.    Company snapshot
8.5.3.    Product Portfolio

8.6.    Lumenis

8.6.1.    Company overview
8.6.2.    Company snapshot
8.6.3.    Operating business segments
8.6.4.    Product Portfolio

8.7.    Medtronic

8.7.1.    Company overview
8.7.2.    Company snapshot
8.7.3.    Operating business segments
8.7.4.    Product portfolio

8.8.    Sciton Inc

8.8.1.    Company overview
8.8.2.    Company snapshot
8.8.3.    Operating business segments
8.8.4.    Product Portfolio

8.9.    Syneron Medical Ltd

8.9.1.    Company overview
8.9.2.    Company snapshot
8.9.3.    Operating business segments
8.9.4.    Product Portfolio
8.9.5.    Key strategic moves and developments

8.10.    WON TECH Co., Ltd

8.10.1.    Company overview
8.10.2.    Company snapshot
8.10.3.    Operating business segments
8.10.4.    Product Portfolio

LIST OF TABLES

TABLE 01.    VARICOSE VEIN TREATMENT MARKET SEGMENTATION
TABLE 02.    TOP INVESTMENT POCKETS
TABLE 03.    TOP PLAYER POSITIONING, 2017
TABLE 04.    IMPACT ANALYSIS
TABLE 05.    GLOBAL VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 06.    VARICOSE VEIN TREATMENT MARKET FOR ENDOVENOUS ABLATION, BY REGION, 2017-2025 ($MILLION)
TABLE 07.    VARICOSE VEIN TREATMENT MARKET FOR INJECTION SCLEROTHERAPY, BY REGION, 2017–2025 ($MILLION)
TABLE 08.    VARICOSE VEIN TREATMENT MARKET FOR SURGICAL LIGATION/STRIPPING, BY REGION, 2017–2025 ($MILLION)
TABLE 09.    GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 10.    VARICOSE VEIN TREATMENT DEVICES MARKET FOR ABLATION DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 11.    GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET FOR PRODUCT, BY TYPE, 2017–2025 ($MILLION)
TABLE 12.    VARICOSE VEIN TREATMENT DEVICES MARKET FOR VENOUS CLOSURE PRODUCTS, BY REGION, 2017–2025 ($MILLION)
TABLE 13.    VARICOSE VEIN TREATMENT DEVICES MARKET FOR VENOUS CLOSURE PRODUCTS, BY REGION, 2017–2025 ($MILLION)
TABLE 14.    GLOBAL VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 15.    GLOBAL VARICOSE VEIN TREATMENT MARKET FOR HOSPITALS, BY REGION, 2017–2025 ($MILLION)
TABLE 16.    GLOBAL VARICOSE VEIN TREATMENT FOR AMBULATORY CENTERS, BY REGION, 2017–2025 ($MILLION)
TABLE 17.    GLOBAL VARICOSE VEIN TREATMENT MARKET FOR CLINICS, BY REGION, 2017–2025 ($MILLION)
TABLE 18.    VARICOSE VEIN TREATMENT MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 19.    NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 20.    U.S. VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 21.    U.S. VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 22.    U.S. VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 23.    CANADA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 24.    CANADA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 25.    CANADA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 26.    MEXICO VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 27.    MEXICO VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 28.    MEXICO VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 29.    NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 30.    NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 31.    NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 32.    EUROPE VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 33.    GERMANY VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 34.    GERMANY VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 35.    GERMANY VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 36.    FRANCE VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 37.    FRANCE VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 38.    FRANCE VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 39.    UK VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 40.    UK VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 41.    UK VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 42.    ITALY VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 43.    ITALY VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 44.    ITALY VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 45.    SPAIN VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 46.    SPAIN VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 47.    SPAIN VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 48.    REST OF EUROPE VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 49.    REST OF EUROPE VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 50.    REST OF EUROPE VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 51.    EUROPE VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 52.    EUROPE VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 53.    EUROPE VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 54.    ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 55.    JAPAN VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 56.    JAPAN VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 57.    JAPAN VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 58.    CHINA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 59.    CHINA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 60.    CHINA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 61.    INDIA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 62.    INDIA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 63.    INDIA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 64.    AUSTRALIA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 65.    AUSTRALIA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 66.    AUSTRALIA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 67.    SOUTH KOREA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 68.    SOUTH KOREA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 69.    SOUTH KOREA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 70.    REST OF ASIA-PACIFIC VARICOSE VEIN TREATMENT PROCEDURE MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 71.    REST OF ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 72.    REST OF ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 73.    ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 74.    ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 75.    ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 76.    LAMEA VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 77.    BRAZIL VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 78.    BRAZIL VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 79.    BRAZIL VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 80.    SOUTH AFRICA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 81.    SOUTH AFRICA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 82.    SOUTH AFRICA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 83.    SAUDI ARABIA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 84.    SAUDI ARABIA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 85.    SAUDI ARABIA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 86.    REST OF LAMEA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 87.    REST OF LAMEA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 88.    REST OF LAMEA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 89.    LAMEA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 90.    LAMEA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 91.    LAMEA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 92.    ANGIODYNAMICS INC: COMPANY SNAPSHOT
TABLE 93.    ANGIODYNAMICS INC: OPERATING SEGMENTS
TABLE 94.    ANGIODYNAMICS INC: PRODUCT PORTFOLIO
TABLE 95.    ALMA LASERS: COMPANY SNAPSHOT
TABLE 96.    ALMA LASERS: PRODUCT PORTFOLIO
TABLE 97.    BIOLITEC AG: COMPANY SNAPSHOT
TABLE 98.    BIOLITEC AG: OPERATING SEGMENTS
TABLE 99.    BIOLITEC AG: PRODUCT PORTFOLIO
TABLE 100.    BTG PLC: COMPANY SNAPSHOT
TABLE 101.    BTG PLC: PRODUCT CATEGORY SEGMENTS
TABLE 102.    BTG PLC: PRODUCT PORTFOLIO
TABLE 103.    ENERGIST LTD: COMPANY SNAPSHOT
TABLE 104.    ENERGIST LTD: PRODUCT PORTFOLIO
TABLE 105.    LUMENIS.: COMPANY SNAPSHOT
TABLE 106.    LUMENIS: PRODUCT PORTFOLIO
TABLE 107.    MEDTRONIC: COMPANY SNAPSHOT
TABLE 108.    MEDTRONIC: PRODUCT CATEGORIES
TABLE 109.    MEDTRONIC: PRODUCT PORTFOLIO
TABLE 110.    SCITON INC: COMPANY SNAPSHOT
TABLE 111.    SCITON INC: OPERATING SEGMENTS
TABLE 112.    SCITON INC: PRODUCT PORTFOLIO
TABLE 113.    SYNERON MEDICAL: COMPANY SNAPSHOT
TABLE 114.    SYNERON MEDICAL: PRODUCT CATEGORIES
TABLE 115.    SYNERON MEDICAL: PRODUCT PORTFOLIO
TABLE 116.    WONTECH CO. LTD: COMPANY SNAPSHOT
TABLE 117.    WONTECH CO. LTD: OPERATING SEGMENTS
TABLE 117.    WONTECH CO. LTD: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR ENDOVENOUS ABLATION, BY COUNTRY, 2017 & 2025 (%)
FIGURE 02.    COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR SCLEROTHERAPY, BY COUNTRY, 2017 & 2025 (%)
FIGURE 03.    COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR SURGICAL LIGATION/STRIPPING, BY COUNTRY, 2017 & 2025 (%)
FIGURE 04.    COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT DEVICES MARKET FOR ABLATION DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 05.    COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT DEVICES MARKET FOR SCLEROTHERAPY INJECTION, BY COUNTRY, 2017 & 2025 (%)
FIGURE 06.    COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT DEVICES MARKET FOR SCLEROTHERAPY INJECTION, BY COUNTRY, 2017 & 2025 (%)
FIGURE 07.    COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 08.    COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR AMBULATORY CENTERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 09.    COMPARATIVE SHARE ANALYSIS OF VARICOSE VEIN TREATMENT MARKET FOR CLINICS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 10.    ANGIODYNAMICS INC: REVENUE, 2016–2018 ($MILLION)
FIGURE 11.    ANGIODYNAMICS INC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 12.    ANGIODYNAMICS INC: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 13.    BTG PLC: NET SALES, 2015–2017 ($MILLION)
FIGURE 14.    BTG PLC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 15.    BTG PLC: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 16.    LUMENIS.: OPERATING SEGMENTS
FIGURE 17.    MEDTRONIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 18.    MEDTRONIC: REVENUE SHARE BY REGION, 2017 (%)

 
 

Varicose veins are abnormal, dilated blood vessels caused by weakening in the vessel’s walls. These veins appear to be swollen, twisted, cluster of blue or purple veins under the skin. The use of devices including endovenous ablation devices and sclerotherapy procedure is expected to increase due to growth in geriatric population and rise in prevalence of varicose vein problem due to engagement in professions which require prolong standing.

Increase in geriatric population and technological advancements and advanced varicose vein treatment devices are expected to fuel the market growth during the forecast period. However, risk factors associated with the treatment devices and healthcare professionals who have less expertise in handling the lasers devices are expected to hinder the growth of the global market.

North America is expected to remain dominant during the forecast period due to supportive reimbursement policies in healthcare system, higher number of varicose vein cases. In addition, Asia-Pacific and LAMEA are expected to provide lucrative opportunities for the growth of the global market during the forecast period due to developments in healthcare infrastructure with a rise in demand for advanced medical facilities and increase in geriatric population.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

Download Sample

OR

Purchase Full Report of
Varicose Vein Treatment Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample

Buy Full Version
"Varicose Vein Treatment Market"
Purchase Enquiry